Select Committee on Science and Technology Minutes of Evidence


Examination of Witnesses (Questions 60-79)

WEDNESDAY 5 FEBRUARY 2003

PROFESSOR MIKE BEVERIDGE, PROFESSOR GERRY GILMORE, PROFESSOR JOHN TURNER AND DR DOUGLAS ROBERTSON

Chairman

  60. You said you were startled about something. What was it you were startled about?
  (Professor Turner) One of my colleagues tried to get some help from the DTI, but the response was the DTI is not here to assist universities.

  61. How do you get on to the DTI, do you pick up a phone and when they say this is the central desk in the DTI do you ask to be put through to somebody? Do you have any contacts there?
  (Professor Turner) It was not me that did this. The DTI do have an office that helps particularly SMEs get involved with European research funding and we thought they might help us as well, but they did not feel they would.

  62. Were they helpful in directing you somewhere else?
  (Professor Turner) They suggested we talk to UKRO.

  63. Just like that?
  (Professor Turner) Yes.

  64. They gave you no advice on how to talk to UKRO, whether to be polite, impolite or whatever?
  (Professor Turner) They were very polite, but they were very clear that it was not their role to assist universities in applying for European research funding.

  65. And you were startled that there was not a system after all this time?
  (Professor Turner) Yes, we were rather.

Geraldine Smith

  66. In your memorandum you mention the selection of priority areas and you do not appear very keen on some of those priority areas, you seem to think that there are some constraints such as SMEs, large industries and partners from the newer Member States. Why do you see that as negative? Is it not an opportunity to work with partners from new Member States?
  (Professor Turner) Yes.

  67. And is it not wise to have partners from large industries involved?
  (Professor Turner) Yes. The reason underlying that particular response was that it can mitigate against the longer-term blue skies research. The need to involve an SME very often means that you cannot propose a project which is very long term blue skies high risk.

  68. But what is wrong with applied research?
  (Professor Turner) There is nothing wrong with applied research, but you do not really need to do both.

  69. So you think that must lead to a real bias against blue skies research?
  (Professor Turner) Yes. At the moment we get funded by the UK Research Councils. Applied research funding we will look to Europe for.

  70. And how will this affect research projects at Surrey that you are currently undertaking?
  (Professor Turner) Framework 6?

  71. Yes.
  (Professor Turner) We wait with interest to see how we get on. We do not know yet. We have a number of applications in, none of them is out.

  72. Is this selection of priority areas a big problem for you or are you just not too clear about how it is going to work?
  (Professor Turner) In some subjects. I am told it varies from subject area to subject area. You will see in the memorandum a collation of responses from right across the whole university. The deepest reservations on the priority areas came from the electronics/IT end of the university; the biotech health care people were happiest.

  73. So it has been a mixed reception?
  (Professor Turner) Yes.

  Chairman: Let us move on to Newcastle and then we might try one or two questions on you as a whole.

Mr McWalter

  74. I want to ask you about the European Research Council. You said that with the Framework 6 Programme the need for a Joint Research Council is in doubt. Why did you say that?
  (Dr Robertson) I do not think I said it was in doubt, I just indicated that I felt the way that things were heading was in favour of a European Research Council but the connectivity to national use needed to be more avert than was present in Framework 5 and probably more overt than appears to be the case in Framework 6. Although there are now far more meetings between heads of the relevant parts of government agencies involved in research which is a positive thing and I am concerned about getting a discontinuity. We have had questions relating to strategic, basic and applied and I think you have to look across the landscape as to where you are putting public funding and make formal decisions as to where you deploy resource. That requires an integrated approach between national and European decision making and I am not sure that we have got there. I suppose I see the European Research Council as being the opportunity to create that connectivity.

  75. Are you like Surrey in that you would apply through the European funding mechanism for more applied research or research that has an interface with industry and that you would look at our own Research Council system in the UK for support for the more blue skies and theoretical work?
  (Dr Robertson) No. I have only been at Newcastle for a month. The request for evidence came to me at Nottingham. The landscape at Newcastle covers all aspects of research ranging from what you might class as near term work with an obvious end point in view with industrial collaborators through to capacity building on the ground as we heard from my colleague from Cambridge, to areas which are strategic in the sense that there is a definite need for thinking about the issues but you cannot quite see what the end product or development might be if it got to the market. When you look at some of the analyses of the European programmes you do get the feeling that the outcomes are more intangible, in the sense of building interaction and co-operation, but actually when you try and find the matrix to test the outputs some of the things do not appear to be happening that one might hope would happen. For example, the number of patents submitted by European organisations to the US Patent Office, you might expect that to have risen significantly in the past decade and it has not, that is a concern. The positive side is that the number of internationally co-authored publications from Europeans is higher than for any other Continental bloc, that must be a positive. Therefore, you may come to an area that may talk about being applied research but a lot of it is much more strategic research and a lot is capacity building rather than strictly applied in form.

  76. I am slightly reluctant to ask you this next question given as you have only been there a month. Do you feel that Newcastle could do well in terms of the priority areas that have been identified for Framework 6 or do you think they have completely ignored X where X is a particular programme that you were very keen on pushing through?
  (Dr Robertson) When you look at where we have expressed interest, it is right across the spectrum so I do not think we would feel there were any particular areas that we were concerned were missing. The concern is that you have to put a large amount of effort in across the spectrum and you do not know whether the success will or will not come. Therefore it is difficult to plan for the outcome because of the attrition rate from application through expression of interest through to full award, and the big concern with Framework 6 is its sheer scale because managing some of those programmes and projects will be the equivalent of managing a medium-sized company with a significant amount of resource and a large number of people employed through the project and it is that scale that is causing some concern in the UK research base.

Chairman

  77. You say that the EU undoubtedly gets value for money from the UK research base. How come?
  (Dr Robertson) Because of the match funding arrangement. As with other governments, the UK puts cash into the EU programme, but if you get more than your juste retour out you are also putting more of your national base in on top of your contribution to EU funding.

  78. And your view about that?
  (Dr Robertson) My view is it is a rather daft way to run a business in the sense that the outcome is one that cannot be planned for, so the impact on a science community is one that is dependent on third party judgment.

  79. So your message to Commissioner Busquin is?
  (Dr Robertson) My message to the Commission and the UK Government is we have to be overt in the decision making and I would prefer to see a rate of indirect cost recovery which is equivalent at least to the Research Councils in the UK such that you felt that one's success was not one which one was going to be worried about if one was too successful.


 
previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries index

© Parliamentary copyright 2003
Prepared 24 July 2003